Medicare Enrolled

Dr. Alexander Rances, D.O.

Acupuncturist · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
305 7TH AVENUE, New York, NY 10001
6466470022
In practice since 2009 (17 years)
NPI: 1235365149 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rances from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rances? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rances

Dr. Alexander Rances is an acupuncturist specialist in New York, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Rances performed 1,331 Medicare services across 567 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rances received a total of $15,305 from 46 pharmaceutical and/or device companies across 433 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in acupuncturist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rances is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 47% volume in NY $15,305 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,331
Medicare services
Top 47% in NY for acupuncturist
567
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~78 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
279 $63 $300
Orthovisc intra-articular injection
An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning.
190 $100 $389
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
160 $107 $319
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
159 $68 $368
Contrast dye for imaging, lower concentration 109 $0 $63
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
68 $1 $10
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
65 $143 $518
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
52 $9 $50
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
48 $225 $800
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
48 $104 $500
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
35 $538 $1,714
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
31 $315 $1,039
Injection, methylprednisolone acetate, 40 mg 23 $6 $40
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
22 $48 $300
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
21 $246 $1,429
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
21 $126 $714
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,305
Total received (2018-2024)
Avg $2,186/year across 7 years
Top 6% in NY for acupuncturist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
433
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,305 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,254
2023
$1,565
2022
$1,439
2021
$2,165
2020
$474
2019
$5,044
2018
$2,363

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$663
Boston Scientific Corporation
$425
Nevro Corp.
$347
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$329
Collegium Pharmaceutical, Inc.
$200
PFIZER INC.
$135
Lundbeck LLC
$73
Medtronic, Inc.
$61
IBSA Pharma Inc.
$21
Top 3 companies account for 63.7% of 2024 payments
All-time payments by company (2018-2024) ›
Nevro Corp.
$3,523
Boston Scientific Corporation
$1,897
ABBVIE INC.
$1,724
Abbott Laboratories
$1,072
BOSTON SCIENTIFIC CORPORATION
$1,011
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$639
Collegium Pharmaceutical, Inc.
$566
Flexion Therapeutics, Inc.
$506
Amgen Inc.
$477
Medtronic USA, Inc.
$460
AbbVie Inc.
$305
DePuy Synthes Sales Inc.
$284
PFIZER INC.
$241
Alexion Pharmaceuticals, Inc.
$237
Bioventus LLC
$200
Vertos Medical, Inc.
$196
Forte Bio-Pharma LLC
$168
SI-BONE, INC.
$143
Medtronic, Inc.
$138
Daiichi Sankyo Inc.
$126
Biohaven Pharmaceutical Holding Company Ltd.
$122
RedHill Biopharma Inc.
$118
Allergan Inc.
$99
Lundbeck LLC
$94
Fidia Pharma USA Inc.
$85
IBSA Pharma Inc.
$81
Scilex Pharmaceuticals Inc.
$80
Horizon Therapeutics plc
$75
SCILEX PHARMACEUTICALS INC.
$70
Almatica Pharma LLC
$69
CATALYST PHARMACEUTICALS, INC.
$67
Novartis Pharmaceuticals Corporation
$66
Allergan, Inc.
$52
BioDelivery Sciences International, Inc.
$52
Teva Pharmaceuticals USA, Inc.
$40
ARBOR PHARMACEUTICALS, INC.
$37
AstraZeneca Pharmaceuticals LP
$30
Vertical Pharmaceuticals, LLC
$25
Horizon Pharma plc
$20
Hikma Pharmaceuticals USA
$19
US WorldMeds, LLC
$18
Saluda Medical Americas, Inc.
$16
Kowa Pharmaceuticals America, Inc.
$16
Zyla Life Sciences
$15
Shionogi Inc
$14
Biohaven Pharmaceuticals, Inc.
$11
Top 3 companies account for 46.7% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · AIMOVIG · AJOVY · AUSTEDO · Aimovig · Axium INS DRG IPG · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · CONFIDENCE SPINAL CEMENT SYSTEM · DUEXIS · Durolane · Evoke SCS · FIRDAPSE · GELSYN 3 · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · HYMOVIS · Horizant · IFUSE IMPLANT · INTELLIS · Kloxxado · LICART · LORZONE · LUCEMYRA · LYRICA · Lucemyra/Lofexidine · METHYLPHENIDATE 72 · MOVANTIK · Morphabond ER · Movantik · NALOCET · NAPRELAN · NURTEC ODT · ORTHOVISC · Omnia · Proclaim Family of SCS IPGs · QULIPTA · RELISTOR · RELISTOR ORAL · RESTORE · SEGLENTIS · SOLIRIS · SPECTRA WAVEWRITER · SPRIX · Senza · Senza Spinal Cord Stimulation System · Soliris · Supartz Fx Sodium Hyaluronate · Symproic · TRILURON · Tirosint · UBRELVY · VYEPTI · Vanta · Varithena Administration Pack · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · mild Device Kit · movantik
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for acupuncturist in NY.

Looking for an acupuncturist specialist in New York?
Compare acupuncturists in the New York area by procedure volume, costs, and industry payment transparency.
Browse acupuncturists nearby

Geographic Context

Acupuncturists within 10 mi
3,400
Per 100K population
208.9
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
1.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rances is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 6% of NY peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rances experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Rances performed 279 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rances receive payments from pharmaceutical companies?
Yes. Dr. Rances received a total of $15,305 from 46 companies across 433 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rances's costs compare to other acupuncturists in New York?
Dr. Rances's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rances) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →